Answers are grounded in this paper and cite their sources.
Oligodendrocyte precursor cells (OPCs) proliferate and differentiate into myelinating oligodendrocytes throughout life, but it is unclear if their continuous self-renewal is balanced by cell death. We find that OPCs do not die during development or adulthood, nor during remyelination, acute systemic inflammation, or aging. These findings challenge the assumption that spontaneous OPC death is common and reveal that OPC homeostasis does not depend on programmed cell death.
No takes yet. Share an insight, caveat, or question.
Kamen et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: